Stentys Revenues for the First 9 Months of 2012 up 88% over Prior Year
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), today reports its third-quarter and 9-month revenues through 30 September 2012.